Adult T-cell leukemia/lymphoma (ATLL) is a malignancy slowly emerging from human T-cell leukemia virus type 1 (HTLV-I)-infected mature CD4
Introduction
Human T-cell leukemia virus type 1 (HTLV-I) is the etiologic agent of a clonal malignancy of mature CD4 þ -helper T cells termed adult T-cell leukemia/lymphoma (ATLL). [1] [2] [3] [4] HTLV-I immortalizes and eventually transforms primary T-cells after a long latency period. 5 However, the mechanism for HTLV-I latency and host T lymphocyte's oncogenic transformation in ATLL remains unclear. We have previously shown that the interleukin (IL)-2-dependent CD4 þ T cell line WE17/10 infected by co-culture with the HTLV-I-producing cell lines, MT-2 or SP1, progressively downmodulated the T-cell antigen receptor (TCR)/CD3 on the cell surface until a complete loss was observed (Akl H et al., submitted). By immunophenotyping, for almost 2 years, an HTLV-I-infected WE17/10 cell line, we observed that, besides the loss of CD3, there was a continuous decrease over time of CD7 membrane expression. It has been shown that fresh ATLL cells are present in the absence of the TCR/CD3 and CD7 molecules on their surface. 6, 7 A correlation between the level of CD3 genes transcription and the CD7 surface expression in adult human marrow T-cell progenitors has also been demonstrated. 8 Furthermore, immunohistochemical studies in ATLL showed that the lack of CD7 expression was a typical characteristic of the malignant lymphocytes. 9 In an effort to characterize the molecular modifications induced by the HTLV-I infection, we started by comparing uninfected TCR/ CD3 þ with HTLV-I-infected TCR/CD3 À WE17/10 cells using micro-arrays and reverse transcription-polymerase chain reaction (RT-PCR). Our data indicated that HTLV-I-infected WE17/ 10 exhibited an early abrogation of tax and rex expression and a progressive diminution of calcium-related genes transcripts. Interestingly, we also found the same phenomenon for CD7 transcripts in the TCR/CD3
À HTLV-I-infected cells. The CD7 antigen is a 40-kDa cell surface glycoprotein, belonging to the immunoglobulin (Ig) gene superfamily, and is found on thymocytes and mature T cells. The function of CD7 is not yet fully understood. It was reported that CD7 delivers a proapoptotic signal during galectin-1-induced T-cell death. 10 Furthermore, CD4 þ CD7 À leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T-cell death. 11 It has also been shown that survival of acute myeloid leukemia cells requires phosphatidylinositol 3-kinase (PI3K) activation. 12 Moreover, a functional association of CD7 with PI3K has been reported. 13 Taken together, our first observations and literature data prompted us to dissect the causes and consequences of this phenomenon in HTLV-I-infected cell lines, followed for 2 years in vitro cultures, performed along lines of investigation:
1. CD7 has been reported to be a co-factor for HIV-mediated cell-to-cell fusion. 14 Furthermore, HIV replicates preferentially in CD7 þ cells. 15 By analogy with what happens in HIV-1-infected cell lines where a decrease in TCR/CD3 expression is mediated by an increased binding of the NFAT/ nuclear factor-kB (NF-kB)-containing complexes to NFAT g1 and NFAT g2 regions in the CD3g promoter, 16, 17 and given the relationship of this observation with modulation of calcium pathways, [18] [19] [20] we focused on binding of NFATc1 and 2 in HTLV-I-infected cells at different stage of infection. This was of possible relevance in CD7 expression as cyclosporin A, a calcineurin inhibitor, blocked ionomycin-induced T-cell CD7 upregulation at the level of transcription and elongation. 21 2. It has been shown that CD7 was upregulated on peripheral blood T-cells following a non-mitogenic ionomycin-induced transmembrane calcium flux, which induced CD7 transcription without affecting CD7 mRNA stability. 22 Furthermore, ligation of CD7 with anti-CD7 mAb induces transmembrane Ca 2 þ flux in T and natural killer (NK) cells. 23 3. We therefore, investigated calcium basal level and its response to stimuli, and found a profound difference between uninfected and HTLV-I-infected cell line, which could explain the differences found in CD7 expression of uninfected and HTLV-I-infected cells at different stage postinfection (p.i.). 4. Finally, we investigated the impact of CD7 downmodulation on apoptotic pathways involving Akt and PI3K. Many of the downstream effects of PI3K are mediated through the protein (serine-threonine) kinase B/Akt. 24 We first used micro-arrays, to compare HTLV-I-infected CD3
À CD7 low cells with uninfected CD3
þ CD7 þ cells, next we looked at the status of proteins downstream of the Akt signaling pathway at different stages of infection and CD7 expression, and finally verified the relevance of these observations on induction of apoptosis of infected and uninfected cells in culture. All these experiments confirmed the link between the initial observation and resistance of infected cells when compared with uninfected cells and provide an explanation of why HTLV-I-infected T-cells are resistant to apoptosis. Ca 2 þ flux deregulation and CD7 downmodulation are responsible for the behavior of HTLV-I-infected cells in comparison with uninfected cells, as far as apoptosis is concerned.
Methods

Cell culture conditions and reagents
The WE17/10 cell line is a human IL-2-dependent CD4 þ T cell line 25 that was established and maintained in RPMI 1640 containing 20% fetal bovine serum (FBS), 1.25 mM L-glutamine, 0.55 mM L-arginine, 0.24 mM L-asparagine and 100 UI/ml of recombinant human IL-2. The MT-2 cell line was derived by coculturing cord blood cells with peripheral blood mononuclear cells from HTLV-I-infected patient.
26 WE17/10 cells were cocultured with irradiated MT-2 cells at a ratio of 1:1 to generate HTLV-I-infected WE17/10 cell lines. The MT-2 cell line was maintained in RPMI 1640 supplemented with 10% FBS.
Flow cytometry
Cells were analyzed for CD7 surface expression by flow cytometry. Briefly, cells were labeled with the murine monoclonal antibody 8H8.1, isotype IgG2a (Beckman Coulter, Belgium, ref: A07755) in a one-step process. The labeled cells were fixed in 2% paraformaldehyde and fluorescence was analyzed on a FACS Caliber (BD Biosciences, Belgium).
RNA extraction and RT-PCR
Total RNA was isolated using the TriPure Isolation Reagent (Roche Applied Science, Belgium). The quality of the RNA was assessed using the Agilent Capiler system. Standard RT was performed using 1 mg of total RNA and 50 ng of the resulting cDNA was used per PCR reaction. We used primer pairs to amplify tax1/rex1 and CD7 according to standard methodology.
Electrophorestic mobility shift assay and supershift assay Nuclear extracts were prepared from 2 Â 10 7 cells. Electrophorestic mobility shift assay (EMSA) and supershift experiments were performed as described by Badran et al., 16 The radiolabeled oligonucleotide probes used for nuclear protein binding were: 5 0 -TCCTTAACGGAAAAACAAAA-3 0 (NFATg 1wt ) and 5 0 -GAGGTGGCTTTCCATTTGGA-3 0 (NFATg 2wt ). Antibodies directed to the NFAT family proteins NFATc1 (SC-7294X) and NFATc2 (SC-7295X) and the NF-kB family proteins p50 (SC-1190X) were purchased from Santa Cruz Biotechnology, Belgium.
Measurement of intracellular calcium
We used fluorescent Ca 2 þ indicator Fluo-3/AM (Sigma, Germany) and fluorescence intensity was measured with a spectro-fluorimeter (Perkin-Elmer, Norwalk, CT, USA), according to a previously described method. 27 Briefly, cells were washed three times in RPMI 1% FBS and 5 Â 10 6 cells/ml were loaded with Fluo-3/AM (8.8 mM) at 371C for 60 min in the dark. After three washes, the cells were suspended in serum-free RPMI (2 Â 10 6 cells/ml) and left at 41C for 30 min.
Oligonucleotide microarray
Total RNA (2-3 mg) was labeled using the BioArray High-Yield RNA Transcript Labeling Kit (Enzo Biochem, New York, NY, USA) following the manufacturer's standard procedures (Affymetrix, Santa Clara, CA, USA). The labeled cRNA were hybridized on test-3 arrays (Affymetrix) to ensure the quality of the probes. The probes were recovered and hybridized on U133A Genechips, containing 22 263 probe sets. The hybridization, washing, staining and scanning of the array slides were performed according to standard protocols (Affymetrix). Each sample was extracted and processed in duplicate, and each RNA was hybridized in duplicate. Gene expression values from the cell intensity files (CEL) files were normalized using Robust multiarray analysis (RMA). 28 Biostatistical analysis was performed using the most stringent way: to select the genes differentially expressed between HTLV-1-infected and uninfected WE 17/10 cells, we apply a novel statistical test specifically developed for the Affymetrix platform. First, we computed the scores and the associated P-values for each comparison between HTLV-1-positive and -negative classes (four possible comparisons). Then, we adjusted these P-values in order to compute the false discovery rates (FDR). Finally, a probeset was considered differentially expressed if the FDR was less than 0.05 for each comparison. The reported fold change is the minimal fold change observed between the two classes. 29 
Western blot analysis
Cells (10 7 ) were resuspended in RPMI 1640 medium and treated or not at 371C with 10 À5 M LY 294002 (CALBIOCHEM) for 1 h. Detection of phospho-Akt (Ser473), phospho-Bad (Ser136) and total Akt were performed using standard immunoblotting procedures. Antibodies were from Cell Signaling (BIOKE, The Netherlands) except the Protein-A peroxidase mAb from Sigma.
Annexin V assay
Cells were incubated in the absence of IL-2 for 48 h. Cells were pelleted by centrifugation and incubated with anti-Annexin V fluorescein isothiocyanate (FITC) and propidium iodide (PI) from BIOSOURCE, Belgium. Single-cell suspensions were analyzed by FACScan (Becton Dickinson, San Jose, CA, USA). Apoptotic cells were scored as Annexin-V þ PI to exclude necrotic cells.
Results
Calcium-related genes expression in HTLV-I-infected WE17/10 cells
We have shown previously that the IL-2-dependent CD4 þ T cell line WE17/10 infected by co-culture with the HTLV-I-producing cell lines MT-2 or SP1 progressively downmodulated its TCR/ CD3 on the surface until a complete loss was observed (Akl H et al., submitted). In an effort to characterize the molecular modifications induced by HTLV-I infection, we compared uninfected TCR/CD3 þ CD7 þ with HTLV-I-infected TCR/ CD3 À CD7 low WE17/10 cells using micro-arrays. mRNA was isolated from either infected or mock-infected WE17/10, then processed to produce biotin-labeled cRNA probes, which were hybridized by the Affymetrix U133A GeneChip Array. Using the above described statistical methods, 30 probesets of genes showed an upmodulation and 83 showed a downmodulation in HTLV-I-infected compared with mock-infected WE17/10 cells (listed in supplementary data). We classified these genes on the basis of their function in various cellular processes. It has been shown that absence of calcium flux after T-cell activation is one of the consequences of the lack of TCR/CD3 expression. 30 Interestingly, our micro-arrays data indicated that HTLV-Iinfected WE17/10 exhibited a dominant downmodulation expression pattern of calcium-related genes ( Figure 1 ): cadherin 1 type 1 E-cadherin (calcium-dependent cell adhesion molecule, CDH1), platelet/endothelial cell adhesion molecule (CD31 antigen or PECAM1) and oncogene related to SRC, FGR, YES (FYN), Annexin A1 (calcium ion-binding, ANXA1), 5-hydroxytryptamine (serotonin)-receptor 3A (HTR3A) and MADS box transcription-enhancer factor 2, polypeptide C (myocyteenhancer factor 2C; MEF2C). These results suggest an alteration of calcium pathways in the HTLV-I-infected cell.
CD7 surface expression after HTLV-I infection and tax1/rex1 gene transcription
RT-PCR and flow cytometry have shown decrease of CD7 transcripts and membrane expression in TCR/CD3
À HTLV-Iinfected WE17/10 cells. A positive correlation has been shown between the level of CD3 genes transcription and CD7 surface expression in adult human marrow T-cell progenitors. 8 Therefore, we followed CD7 membrane expression in HTLV-Iinfected lines maintained in culture for more than 2 years. To avoid variations in the fluorescence intensity between labeling experiments, we used cells cryopreserved at different time points and thawed them simultaneously before flow cytometry assay. We could so establish a sequential quantitative analysis, according to time, in culture after infection (Figure 2a ). CD7 We used a RT-PCR with the previously described primers RPX3 and RPX4 to examine tax1/rex1 proviral gene transcription during the progression of HTLV-1-infected cells from CD7 þ -CD7 low -CD7 À (Figure 2b ). Total RNA from uninfected and HTLV-I-infected WE17/10 cells with different CD7 surface density were tested for tax1/rex1 mRNA expression. Although we could not detect any band for the uninfected cells (lane 5), a drastic decrease in the tax1/rex1 PCR band intensity was observed when comparing 100% CD7 þ HTLV-I-infected cells (lane 4) with 95% CD7 þ (lane 3). The tax1/rex1 band disappeared when we used RNA from 80% CD7 þ (lane 2) and remained negative throughout until all the cells became CD7 À (lane 1). This silencing of tax1/rex1 proviral expression was thus an early phenomenon, occurring around week 12, well before the disappearance of CD7 and CD3. This result suggests that the initial expression of HTLV-I is needed to launch the process, but not for it to go on.
The amount of nuclear NFATc1, NFATc2 and NF-kB p50 is positively correlated with TCR/CD3 and CD7 surface expression in HTLV-I-infected WE17/10 cells
The promoter of the CD3g gene was identified in our lab and two NFAT-binding sites: NFAT g1 (À124 to À120) and NFAT g2 (À384 to À380) were widely studied. 16, 17 The composition of the complexes that bind to each site in TCR/CD3
þ HTLV-Iinfected WE17/10 was determined using supershift experiments (Figure 3a) . Antibody specific to NFATc2 supershifted a NFAT g1 .protein complex (line 2) and a NFAT g2 protein complex (line 7), whereas antibodies specific to NFATc1 and NF-kB p50 supershifted a NFAT g1 protein complex (lines 3 and 4, respectively), they failed to supershift with NFAT g2 probe (lines HTLV-I infection of WE17/10 CD4 þ cell line H Akl et al 8 and 9, respectively). As in HIV-infected cells, complexes containing NFATc1 and NF-kB p50 bound to NFAT g1 , whereas a complex containing NFATc2 bound to NFAT g2 in the nucleus of HTLV-I-infected cells. Our previous study showed a correlation between the presence of NFATc1, NFATc2 and NF-kB p50 in the nucleus and the TCR/CD3 cell surface concentration after HIV-1 infection. 16, 17 However, cyclosporin A blocked ionomycininduced T cell CD7 upregulation at the level of mRNA transcription and elongation. 21 We examined the differential binding to the NFAT g1 and to the NFAT g2 probe of nuclear extracts during the progression of HTLV-1-infected cells from TCR/CD3
þ -TCR/CD3 lo -TCR/CD3-and from CD7 þ -CD7 low -CD7- (Figure 3b) . A decrease in binding of the NFAT/NF-kB-containing complexes to NFAT g1 and NFAT g2 was observed in uninfected 100% of TCR/CD3 and CD7 (lines 1 and 8) to infected 95% TCR/CD3 and 90% CD7 (lines 2 and 9) to 70% TCR/CD3 and 80% CD7 (lines 3 and 10) to 20% TCR/CD3 and 60% CD7 (lines 4 and 11) to 0% TCR/CD3 and 40, 10 and 0% CD7, respectively (lines 5, 6, 7 and 12, 13 and 14) in comparison with normal receptor levels. This impairment in binding to NFAT g1 and NFAT g2 probes is specific because similar amounts of the constitutively expressed Oct-1 protein from each extract bound to an Oct-1 sequence-specific probe (data not shown). These results suggest that in contrast to HIV-1, a positive correlation exists here between the quantity of NFATc2, and NFATc1 and NF-kB p50, in the nucleus and the expression of TCR/CD3 complexes after HTLV-I infection. In addition, the decline in the nuclear localization of the NFAT/ NF-kB complexes correlated with the decreased CD7 expression at the surface of HTLV-I-infected cells.
Calcium signal of ionomycin-treated HTLV-I-infected WE17/10 cells
Previous studies have shown that CD7 was upregulated in peripheral blood T-cells following a non-mitogenic ionomycininduced transmembrane Ca 2 þ flux, which induced CD7 transcription without affecting CD7 mRNA stability; 22 further- 
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Tax/Rex . We observed that a decline in the Ca 2 þ -dependent nuclear localization of the NFAT timely correlated with decreased CD7 membrane expression. We also demonstrated that HTLV-I-infected WE17/ 10 cells showed attenuated responses to ionomycin stimulus compared with mock-infected WE17/10 cells. This progressive loss of ionomycin-induced Ca 2 þ flux was correlated with the loss of CD7 expression (Figure 4) . The reduction was about twofold in CD7 low cells, whereas it was about eightfold in the CD7 À cells.
Apoptosis-related genes expression in HTLV-I-infected cells
The above experiments have shown that CD7 surface receptors are progressively downmodulated after HTLV-I infection. CD7 delivers a pro-apoptotic signal during galectin-1-induced T-cell death. 10 We focused in our micro-array list of significantly modulated genes on apoptosis-related genes and their potential relationship with CD7 ( Figure 5 ). Apoptosis-induction genes were generally downmodulated, CDH1, FYN, ANXA1 (cited above with the calcium-related genes), granulysin (GNLY), dual specificity phosphatase 6 (DUSP6), granzyme B and A (granzyme 2 and 1, cytotoxic T-lymphocyte-associated serine esterase 1 and 3, GZMB and GZMA), G protein-coupled receptor 65 (GPR65), v-jun sarcoma virus 17 oncogene homolog (avian, JUN) and integrin beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12, ITGB1) whereas only two of them were upmodulated, lectin galactoside-binding soluble 1 and 3 (galectin-1 and -3, LGALS1 and LGALS3). In addition, the survival gene, amyloid beta (A4) precursor protein (APP) was upmodulated. Although intracellular galectin-3 blocks T-cell death, 31 the CD4 þ CD7 À leukemic T-cells from patients with Sezary syndrome were protected from galectin-1-triggered T-cell apoptosis. 11 This suggests that the P-labeled NFAT g1 and NFAT g2 probes were used in a supershift assay with nuclear extracts from CD3 þ CD7 þ HTLV-1-infected cells in the absence of antibodies (lanes 1 and 6) or in the presence of anti-NFATc2 (lanes 2 and 7), anti-NFATc1 (lanes 3 and 8) , anti-NF-kB p50 (lanes 4 and 9) and free probe (lanes 5 and 10). (b) Correlation between TCR/CD3 and CD7 surface expression and binding of NFATc1, NFATc2 and NF-kB p50 to the NFAT g1 and NFAT g2 probes. EMSA experiments were performed with the 32 P-labeled NFAT g1 and NFAT g2 probes and nuclear extracts from uninfected 100% TCR/CD3 100% CD7 (lines 1 and 8), 95% TCR/CD3 90% CD7 (lines 2 and 9), 70% TCR/CD3 80% CD7 (lines 3 and 10), 20% TCR/CD3 60% CD7 (lines 4 and 11), 0% TCR/CD3 40, 10 and 0% CD7, respectively (lines 5, 6, 7 and 12, 13, 14) HTLV-I-infected cells.
HTLV-I infection of WE17/10 CD4
þ cell line H Akl et al effect of galectin-1 upregulation is prevented by CD7 loss, leading to a progressive shift to dominant antiapoptotic environment in HTLV-I-infected cells.
Constitutive activation of Akt and Bad in HTLV-I-infected WE17/10 cells
Previous experiments showed that CD7 interacts with PI3K via a YEDM motif. 32 Furthermore, activation of PI3K/Akt signaling is involved in fibroblast Rat-1 transformation by HTLV-I. 33 To investigate the status of Akt phosphorylation in HTLV-I-infected WE17/10, we carried out Western blots with phospho-specific antibody against Akt phosphorylated at Ser473 (Figure 6a) . We compared CD7 þ uninfected WE17/10 with HTLV-I-infected CD7 low or CD7 À cells. Phosphorylated Akt protein was detected in HTLV-I-infected and not in uninfected WE17/10 cells. However, the phosphorylation level of the Akt protein was lower in CD7 low than in CD7 À HTLV-I-infected cells. Akt phosphorylation was PI3K-dependent as it was reduced in HTLV-I-infected cells treated with the PI3K inhibitor LY294002. However, LY294002 had no effect on the total level of Akt (lower panel). It has been shown that the pro-apoptotic function of Bad is regulated by the PI3K/Akt pathway. 34 Furthermore, Akt phosphorylates Bad both in vitro and in vivo and blocks the Badinduced death of primary neurons in a site-specific manner. 34, 35 Akt-mediated phosphorylation at Ser112 and Ser136 prevents Bad binding to its antiapoptotic partner Bcl-xL. We did not detect any difference in BCL-xL expression between uninfected and HTLV-I-infected cells (data not shown). We therefore used phospho-specific antibody against Bad phosphorylated at Ser136 in a Western blotting assay. Consistent with our results on Akt, we found that Bad was phosphorylated in HTLV-Iinfected but not in uninfected WE17/10 cells (Figure 6b ) and once again the expression level of phosphorylated Bad in CD7 low cells was weaker than in CD7 À cells. Bad phosphorylation in HTLV-I cells was PI3K-dependent, as it was reduced when the cells were treated with the PI3K inhibitor LY294002. To ensure that substrate was not lost with handling, blot was stripped and reprobed using an antibody that recognized total Akt (lower panel). Taken together, increased Akt and Bad phosphorylation in parallel with CD7 surface downmodulation suggests a potential correlation between the loss of CD7 expression and the constitutive PI3K/Akt signaling activation after HTLV-I infection.
Growth level of HTLV-I-infected WE17/10 and apoptosis PI3K/Akt signaling pathway is constitutively induced in HTLV-Iinfected WE17/10 cells. To investigate the effect of this constitutive activation of Akt on cell growth, we compared the expansion of the HTLV-I-infected WE17/10 with the uninfected WE17/10 cells cultured in complete and IL-2-deprived medium (Figure 7a and b) . In complete medium, CD7 þ uninfected and CD7 À and CD7 low HTLV-I-infected WE17/10 cells grew normally, and there was no significant difference in the number of cells in apoptosis, assayed at day 2. In contrast, in IL-2-deprived medium, HTLV-I-infected CD7 À WE17/10 cells continued to grow, whereas CD7 low cells seemed to be affected and the uninfected WE17/10 were almost all dead by day 3. This resistance of CD7 À cells was reversed by the addition of LY294002. As a decrease in cell number may result either from apoptosis or from a block of the cell cycle, our findings about constitutive activation of Akt and Bad were in favor of the first explanation. To confirm this hypothesis, cells were incubated for 48 h in an IL-2-deprived medium and assayed for the binding of Annexin V and the incorporation of PI. As shown in Figure 7c , 46% of uninfected WE17/10 cells underwent apoptosis in the absence of IL-2, as opposed to only 5% of CD7 low and less than 2% of CD7 À HTLV-I-infected WE17/10 cells. It was impossible to perform this assay at day 3, where the difference in cell 
Discussion
In our previous work, we have shown that TCR/CD3 loss after HTLV-I infection was owing to the initial loss of CD3g gene transcripts (Akl et al., submitted). In an effort to characterize the molecular modifications induced by HTLV-I infection, we compared uninfected TCR/CD3 þ with HTLV-I-infected TCR/ CD3 À WE17/10 cells using micro-arrays. Overall, using the most stringent statistical method, 30 probesets of genes were upregulated and 80 were downmodulated in HTLV-I-infected WE17/10 cells when compared with mock-infected WE17/10 cells. Many calcium-related genes transcripts implicated in different cellular pathways were significantly decreased. Interestingly, reduced expression of one of them (CDH1) is regarded as one of the main molecular events involved in dysfunction of the cell-cell adhesion system, triggering cancer invasion and metastasis. We next focused on calcium flux regulation and found, consistently with our micro-array data, a profound decrease in HTLV-Iinfected cell lines in terms of intracellular calcium levels in response to ionomycin. Importantly, we found the ionomycininduced Ca 2 þ flux correlated with CD7 expression level at different stages post-HTLV-I infection. CD7 surface expression in the HTLV-I-infected WE17/10 undergoes a progressive decrease, whereas it remains stable in the control cells. T-cell CD7 gene transcription has been shown to be induced by non-mitogenic ionomycin-induced transmembrane calcium flux. 22 Knowing that CD7 delivers a pro-apoptotic signal during galectin-1-induced Tcell death 10 and that CD4 þ CD7 À leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered Tcell death, 11 we went back to our micro-arrays data. Some of the calcium-related genes progressively downregulated after HTLV-I infection are implicated in apoptosis: PLA2G4A, 36 ITPR1 and ITPR2. In early apoptosis, cytochrome-C is released in the endoplasmic reticulum, where it selectively binds ITPR1, resulting in sustained oscillatory cytosolic calcium increases. 37 We focused on apoptosis-related genes and their potential relationship with CD7 in our micro-arrays analysis. Apoptosis induction genes were generally downmodulated. No effect was observed in antiapoptotic genes transcripts, suggesting that the phenomenon results from apoptosis blockade rather than reduction in antiapoptotic pathways. Interestingly, recent studies suggest that one of them, DUSP6 acts as a tumor-suppressor gene.
38 Surprisingly, galectin 1 (LGALS1) transcripts were augmented. This suggests that the pro-apoptotic signal of galectin-1 can be blocked by CD7 loss, shifting even more the balance towards a dominant antiapoptotic environment in HTLV-I-infected cells.
Other studies have shown that survival of acute myeloid leukemia cells requires PI3K activation 12 and that a functional association exists between CD7 and PI3K. 13 Activation of PI3K/Akt signaling is involved in fibroblast Rat-1 transformation by the HTLV-I tax protein. 33 It has been shown that survival factors can suppress apoptosis by activating Akt, which then phosphorylates and inactivates components of the apoptotic machinery, including Bad. 35 Looking at the phosphorylation status of Akt and Bad, we found that Akt and Bad proteins were phosphorylated only in HTLV-I-infected cells. Furthermore, Akt and Bad phosphorylation increased with time p.i. in parallel with the progressive loss of CD7 expression. The phosphorylation of both proteins was found to be PI3K-dependent as it was reduced in HTLV-I-infected cells treated with the PI3K inhibitor LY294002. We finally investigated the effect of this constitutive activation of PI3K/Akt on cell growth and found that HTLV-I-infected WE17/10 cells are more resistant to the apoptotic effect of IL-2 deprivation than the uninfected WE17/10. This phenomenon was inversely correlated with CD7 cell surface density and could be reversed by PI3K-selective inhibitors. We thus propose a model in which, after HTLV-I infection, a progressive deregulation in Ca 2 þ influx, possibly owing to loss of CD3 expression, leads to an increase of Akt and Bad phosphorylation in parallel with a progressive loss of CD7 expression, reflecting an inverse correlation between CD7 expression and PI3K/Akt signaling activation.
As far as the link between calcium deregulation, decreased binding of the NFAT/NF-kB-containing complexes to NFATbinding sites in the CD3g promoter and loss of CD3 expression is concerned, it is difficult to prove our hypothesis definitely: HTLV-I infection starts a process that leads, despite the early silencing of the integrated provirus, to a loss of CD3 expression, which in turns leads to a profound decrease in calcium response to ionomycin. 30 This perturbation leads to loss of CD7 (a receptor for apoptotic signals) and activation of the antiapoptotic Akt/Bad pathway, via PI3K activation and eventually to resistance to apoptosis. We have shown a progressive decrease in NFAT/NF-kB complexes binding to the CD3g-promoter region in infected WE17/10 cells. But NFAT nuclear translocation is regulated by transmembrane calcium flux, 19 ,20 therefore we cannot rule out that the first hit is the calcium flux modification. This will be the matter of future work. Anyway, the activation of the Akt/Bad pathway via PI3K activation remains firmly demonstrated, as well as its consequence on CD3-, CD7-infected cells in terms of resistance to the apoptotic effect of IL-2 deprivation in culture, rendering these cells independent from growth factor, a phenomenon described in human ATLL cells. 9 Our data provide an explanation and the evidence for a phenomenon (progressively acquired IL-2 independence) in HTLV-I-infected cells in vitro. We conclude that this progressive increased resistance to apoptosis, at a time HTLV-I genes expression is silenced, helping to escape immune surveillance, could be one of the major event in the process of full malignant transformation into ATLL in infected patients. Lysates from CD7 þ uninfected, CD7 low and CD7 À HTLV-I-infected were tested for (a) Akt and (b) bad phosphorylation. Cells were exposed (lanes 2, 4 and 6) or not (lanes 1, 3 and 5) to 10 À5 M of the LY 294002 PI3K inhibitor for 1 h before harvesting and analysis by Western blotting. To ensure that substrate was not lost during the procedure, the blot was stripped and reprobed using an antibody that recognized total Akt (the lower panel each time).
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